The global bioreactors and fermenters market is expected to grow from USD 25.9 billion in 2024 to USD 29.1 billion in 2026 and USD 73.7 billion by 2035, at CAGR of 10.9%during the forecast period till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market.
The latest study is inclusive of an in-depth analysis of the economic status of the Fermenters and Bioreactors Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries.
Key factors affecting the growth of the Fermenters and Bioreactors Market:
Geographical Overview:
Competitive Hierarchy:
Key players
Bionet, Cytiva, Eppendorf, Merck, Ollital Technology, Parr Instrument Company, Sartorius, Shanghai Bailun Biological Technology, Solaris Biotech, Solida Biotech
Additional parameters of the Fermenters and Bioreactors Market report:
Additional Insights:
Bioreactors are capable of providing such optimal conditions and are critical to the upstream manufacturing processes. These systems are designed to increase the concentration of viable cells, thereby enabling the production of large amounts of recombinant proteins, such as vaccines, fusion proteins, antibodies and enzymes. Apart from producing conventional therapeutic proteins, bioreactors can also be used to produce advanced medicinal products (ATMPs), namely cell and gene therapy, retroviral vectors for gene therapy and cellular components of 3D tissue. In contrast to bioreactors, fermenters are used for the anaerobic cultivation of microbial (fungal or bacterial) cell populations to produce biologics that do not require significant post translational modifications. It is worth highlighting that the use of fermenters for the manufacturing of biologics provides faster development, higher yields and quality, reduced variation between batches, better scalability, and lower production costs, in comparison to the manufacturing carried out in bioreactors.
The Global Fermenters and Bioreactors Market- Distribution by Type of Product (Bioreactors and Fermenters), Fabrication Material (Glass, Stainless Steel and Single-use), Type of Bioprocess (Batch, Fed-batch and Continuous), Type of Biologic (Antibodies, Vaccines, Cell Therapies and Other Biologics), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts, Till 2035 market report features an extensive study of the current market landscape, market size, and future opportunities for the global bioreactors market and global fermenters market, during the given forecast period. Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the bioprocess engineering industry. Key takeaways of the bioreactors and fermenters market report are briefly discussed below.
Over the past 25 years, there has been a steady increase in the sales of biologics, growing at a rate of 12–14% annually. In order cater to this growing market demand, over 1,500 commercial scale biomanufacturing and contract manufacturing organization (CMO) facilities, equipped with bioreactors and / or fermenters have been established, globally. In December 2022, Thermo Fisher Scientific opened a cGMP biologics manufacturing facility in Hangzhou, China. The facility is equipped with Thermo Fisher 2,000-liter HyPerforma single use bioreactors.
Further, during the COVID-19 pandemic, several companies enhanced their vaccine production capabilities (through capacity expansion / technology upgradation), resulting in a surge in the sales of bioreactors and fermenters. Moreover, the transition in the industry from high-volume biologics towards innovative specialized biologics, particularly those focused on treating rare conditions, has created a requirement for flexible manufacturing systems. Consequently, there is an increasing demand for a diverse range of bioreactor systems (in term of design and mechanism of action), which primarily include single use bioreactor, stirred tank bioreactor, mini bioreactor, and air lift bioreactor, along with other bioreactor systems such as, rocker, perfusion, wave bed, bubble column, fixed-bed, fluidized bed, membrane bioreactor, packed bed, fibrous bed and photobioreactors. All these developments represent an additional avenue for revenue generation in the growing fermenters and bioreactors market during the forecast period.
Research objectives:
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/bioreactors-and-fermenters-market.html
© 2025 Crivva - Hosted by Airy Hosting Managed Website Hosting.
